895795-22-9

Upstream product

• 4892-02-8 Methyl thiosalicylate 
• 329-59-9 4-fluoro-3-nitro-benzoic acid methyl ester 
• 1319194-14-3 methyl 3-amino-4-((2-(methoxycarbonyl)phenyl)thio)-benzoate 
• 1319194-13-2 methyl 4-((2-(methoxycarbonyl) phenyl) thio)-3-nitrobenzoate 
• 440627-10-1 3-amino-4-(2-carboxy-phenylsulfanyl)-benzoic acid 
• 440627-14-5 11-oxo-10,11-dihydro-dibenzo [b,f][1,4]thiazepine-8-carboxylic acid 
• 897771-13-0 methyl 11-oxo-10,11-dihydrodibenzo[b,f][1,4]-thiazepine-8-carboxylate 
• 766-80-3 1-bromomethyl-3-chlorobenzene 

Downstream Products

• 897772-23-5 C₂₁H₁₄ClNO₃S 
• 1319194-05-2 10-(3-chlorobenzyl)-N-(3-(cyclohexyl(methyl)amino)-propyl)-11-oxo-10,11 dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide 

Relevant academic research and scientific papers

Evaluation of NTF1836 as an inhibitor of the mycothiol biosynthetic enzyme MshC in growing and non-replicating Mycobacterium tuberculosis

The mycothiol biosynthesis enzyme MshC catalyzes the ligation of cysteine with the pseudodisaccharide GlcN-Ins and has been identified as an essential enzyme in Mycobacterium tuberculosis. We now report on the development of NTF1836 as a micromolar inhibi